Vanguard Personalized Indexing Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.9K Buy
+1,232
New +$12K ﹤0.01% 2144
2025
Q4
Sell
-1,063
Closed -$25.8K 1997
2025
Q3
$25.8K Buy
+1,063
New +$17.7K ﹤0.01% 1956

Other funds holding CDLX

Vanguard Personalized Indexing Management's CDLX Position: Q1 2026 in Review

Vanguard Personalized Indexing Management opened a new position in Cardlytics (CDLX) in Q1 2026: 1,232 shares worth $12.9K. The stake represents ﹤0.01% of the portfolio and ranks #2144 among its holdings. This is a return to the name: Vanguard Personalized Indexing Management previously reported a position in CDLX as recently as Q3 2025.

Vanguard Personalized Indexing Management first reported a position in CDLX in Q3 2025 and has held it in 2 quarters since. The position peaked at $25.8K in Q3 2025. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Vanguard Personalized Indexing Management held 1,232 shares of Cardlytics worth $12.9K as of Q1 2026.
  • Cardlytics was a new Vanguard Personalized Indexing Management position in Q1 2026.
  • Cardlytics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #2144 holding.
  • Vanguard Personalized Indexing Management first reported a position in Cardlytics in Q3 2025 and has held it in 2 quarters since.
  • Vanguard Personalized Indexing Management's Cardlytics position peaked at $25.8K in Q3 2025.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.